Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
ObjectiveEmerging evidence showed that immune checkpoint inhibitors (ICIs) lead to hyperprogressive disease (HPD) in a small proportion of patients. There is no well-recognized standard for the evaluation of HPD. Comprehensive exploration of HPD definition system in gastrointestinal cancer treated w...
Saved in:
Main Authors: | Zhenghang Wang, Chang Liu, Yuezong Bai, Xiaochen Zhao, Longgang Cui, Zhi Peng, Xiaotian Zhang, Xicheng Wang, Zhengyi Zhao, Jian Li, Lin Shen |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/dc2063dc3e28419fbe5a61234b8e96fb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer
by: Zhihao Lu, et al.
Published: (2021) -
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
by: Po-Han Lin, et al.
Published: (2021) -
Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
by: Vasiliki Pisanidou, et al.
Published: (2021) -
TUMOR ESTROMAL GASTROINTESTINAL (GIST): FORMAS DE PRESENTACION
by: Oyanedel Q,Roberto, et al.
Published: (2005) -
Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer
by: Jill P. Smith, et al.
Published: (2021)